|
ORC4L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.36599653599978E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.40929995135531E-09 |
| Normal-vs-Stage2 |
2.37749999999481E-05 |
| Normal-vs-Stage3 |
7.37890004653963E-09 |
| Normal-vs-Stage4 |
1.46220000551978E-08 |
| Stage1-vs-Stage2 |
8.533200E-01 |
| Stage1-vs-Stage3 |
1.912220E-01 |
| Stage1-vs-Stage4 |
6.652400E-02 |
| Stage2-vs-Stage3 |
4.777800E-01 |
| Stage2-vs-Stage4 |
2.676600E-01 |
| Stage3-vs-Stage4 |
6.123400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.68699507088854E-11 |
| Normal-vs-AfricanAmerican |
5.041500E-03 |
| Normal-vs-Asian |
2.1921999999952E-05 |
| Caucasian-vs-AfricanAmerican |
2.106400E-01 |
| Caucasian-vs-Asian |
5.584200E-01 |
| AfricanAmerican-vs-Asian |
4.600800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.18139999794442E-08 |
| Normal-vs-Female |
9.64889945720415E-10 |
| Male-vs-Female |
4.576600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.61990000489143E-08 |
| Normal-vs-Age(41-60Yrs) |
9.77189995587935E-09 |
| Normal-vs-Age(61-80Yrs) |
2.55770005175293E-09 |
| Normal-vs-Age(81-100Yrs) |
2.339500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.943000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.642240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.971800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.454800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.882400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.760400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.504800E-01 |
| Classical-VS-Follicular |
8.735800E-01 |
| Classical-VS-Other |
7.785000E-01 |
| Classical-VS-Normal |
7.68890000002465E-07 |
| Tall-VS-Follicular |
3.585800E-01 |
| Tall-VS-Other |
4.542200E-01 |
| Tall-VS-Normal |
2.53539999994778E-06 |
| Follicular-VS-Other |
8.765200E-01 |
| Follicular-VS-Normal |
5.56889999999699E-05 |
| Other-VS-Normal |
6.910000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.26640001105483E-09 |
| Normal-vs-N1 |
3.92650000291539E-08 |
| N0-vs-N1 |
1.907200E-01 |
|
|
